{
  "title": "Bonus: What You Need to Know About the Novavax COVID-19 Protein-Based Vaccine",
  "itunes:title": "Bonus: What You Need to Know About the Novavax COVID-19 Protein-Based Vaccine",
  "pubDate": "Thu, 16 Jun 2022 12:48:40 +0000",
  "guid": "8f7d6944-e9a1-497e-a03b-0c8c75d1305e",
  "link": "https://johnshopkinssph.libsyn.com/bonus-what-you-need-to-know-about-the-novavax-covid-19-protein-based-vaccine",
  "itunes:image": "",
  "description": "<p><span style=\"font-weight: 400;\">An FDA advisory panel recommended Emergency Use Authorization for the two-dose Novavax COVID-19 vaccine for people ages 18+. The vaccine is built on a different technology than others currently authorized in the US, and significant delays in manufacturing and authorization have slowed down its entry into the US market. Vaccine expert</span> <strong>Dr. Bill Moss</strong> <span style= \"font-weight: 400;\">returns to the podcast to talk with</span> <strong>Lindsay Smith Rogers</strong> <span style= \"font-weight: 400;\">about Novavax and its potential and what’s behind the delays. </span></p>",
  "content:encoded": "<p>An FDA advisory panel recommended Emergency Use Authorization for the two-dose Novavax COVID-19 vaccine for people ages 18+. The vaccine is built on a different technology than others currently authorized in the US, and significant delays in manufacturing and authorization have slowed down its entry into the US market. Vaccine expert Dr. Bill Moss returns to the podcast to talk with Lindsay Smith Rogers about Novavax and its potential and what’s behind the delays. </p>",
  "enclosure": "",
  "itunes:duration": "16:58",
  "itunes:explicit": false,
  "itunes:keywords": "FDA,Pandemic,EUA,vaccines,coronavirus,covid,novavax",
  "itunes:subtitle": "An FDA advisory panel recommended Emergency Use Authorization for the two-dose Novavax COVID-19 vaccine for people ages 18+. The vaccine is built on a different technology than others currently authorized in the US, and significant delays in...",
  "itunes:season": 6,
  "itunes:episodeType": "bonus",
  "itunes:author": "The Johns Hopkins Bloomberg School of Public Health"
}